Related Experiment Videos
An approach to the problem of heterogeneity of human tumour-cell populations
Abstract:
1. Successive sampling of ovarian cancers during cytostatic treatment showed several cases of notable changes in their ploidy distribution and one change in model chromosome number, indicating selection of a resistant tumour-cell population. 2. Studies of cell suspensions from human tumour specimens incubated with [3H]-TdR after exposure in vitro to various cytostatic agents have shown variation in labelling between different parts of the same tumour, as well as between the primary tumour and its metastases or ascitic tumour-cell population, which may be accounted for by variation in sensitivity of the tumour-cell population. 3. Studies of nuclear morphology in 20 endometrial cancers before and after progesterone therapy demonstrate considerable variation in the proportion of cells undergoing secretory conversion within the same tumour, indicating primary heterogeneity of the tumour-cell population in response to progesterone.
Insights
Tumor cell populations exhibit heterogeneity, developing resistance to cytostatic drugs and hormonal therapies. This variation in sensitivity impacts treatment effectiveness in ovarian and endometrial cancers.
Area of Science:
- Oncology
- Cancer Biology
- Genetics
Background:
- Tumor heterogeneity is a significant challenge in cancer treatment.
- Understanding cellular responses to therapy is crucial for improving outcomes.
- Previous studies suggest variations within tumor cell populations.
Purpose of the Study:
- To investigate tumor cell population heterogeneity in response to cytostatic and hormonal therapies.
- To identify mechanisms of treatment resistance in ovarian and endometrial cancers.
- To analyze changes in ploidy, chromosome number, and nuclear morphology.
Main Methods:
- Successive sampling of ovarian cancers during cytostatic treatment.
- In vitro incubation of human tumor cell suspensions with [3H]-thymidine (TdR) after exposure to cytostatic agents.
- Analysis of nuclear morphology in endometrial cancers before and after progesterone therapy.
Main Results:
- Ovarian cancers showed changes in ploidy distribution and chromosome number, indicating selection of resistant cells.
- Variations in [3H]-TdR labeling were observed within tumors and between primary and metastatic sites, suggesting differential sensitivity.
- Endometrial cancers displayed heterogeneity in secretory conversion, indicating varied responses to progesterone.
Conclusions:
- Tumor cell populations are inherently heterogeneous, influencing treatment response.
- This heterogeneity contributes to the development of resistance to cytostatic drugs and hormonal therapies.
- Targeting specific subpopulations or overcoming heterogeneity may be key to effective cancer treatment.